IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

New Route to Hepatitis Drug

10:08 AM MDT | July 23, 2007 | Chemical Week Editorial Staff

Researchers at Imperial College, part of the University of London, say they have identified a novel synthetic route to produce pegylated interferon, a drug currently produced by Roche to treat hepatitis C. The product developed by the Imperial College researchers would not be covered by Roche’s patent, which covers production of interferon coated with...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa